1. When uracil-2-C14 was administered to tumor-bearing rats, it was utilized for acid-soluble nucleotide formation and RNA and DNA nucleic acid pyrimidine biosynthesis to a much greater extent by the Flexner-Jobling carcinoma and intestinal mucosa than by liver.

  2. In a direct comparison of the utilization of uracil-2-C14 and orotic acid-4-C14 in vivo, the latter was incorporated into acid-soluble and nucleic acid pyrimidines to a much greater extent in the liver. In intestinal mucosa orotic acid was more efficiently utilized than uracil, while in the tumor the two precursors were incorporated to the same extent.

  3. In the soluble, high-speed supernatant fraction obtained from homogenates of liver and Flexner-Jobling carcinoma, there was an extensive conversion of orotic acid into the acid-soluble uridine nucleotides and a much lesser utilization of uracil. There was a somewhat higher conversion of dihydrouracil into nucleotides than of uracil. Extensive catabolism of both uracil and dihydrouracil was observed in this system derived from liver; very little was obtained in the tumor system.

This content is only available via PDF.
©1957 American Association for Cancer Research.
1957
Cancer Research, Inc.
You do not currently have access to this content.